Antiviral Research: Strategies in Antiviral Drug Discovery

Antiviral Research: Strategies in Antiviral Drug Discovery
2009 © American Society for Microbiology
Robert L. LaFemina Ph.D.
ISBN-13: 978-1-55581-439-7
Virology, Pharmacy/Pharmacology, Research


This title captures the state of the science with twenty reviews that examine the latest in today's antiviral drug discovery efforts. The introduction of nucleoside analogs and investigations of novel antiviral targets have brought significant new possibilities to the field. These reviews range from in-depth analyses of a specific viral target, to examination of multiple targets in medically important viruses. All chapters include the authors' thoughts regarding future developments in their specific topic, and the book concludes with an Afterword in which several experts consider the general future of antiviral drug discovery.

With its coverage of many different types of viruses including influenza virus, herpesvirus, the SARS coronavirus, orthopox- and flaviviruses, hepatitis C virus, and a wide range of topics in HIV-1, Antiviral Research offers investigators a broad view of the current state of nucleoside analogs and other antiviral strategies. This book is certain to help stimulate new ideas and approaches for virologists, biochemists, pharmaceutical chemists, and other investigators.

Key Features:

  • • Covers a broad range of viruses, including HIV-1, HSV, and HCV
  • • Presents the fundamental principles of antiviral agents and forecasts future possibilities
  • • Investigates novel enzyme and protein inhibitors
  • • Analyzes clinical aspects of viral infection with regard to treatment and toxicity
  • • Examines known and potential targets at all stages of viral development
  • • International author group represents both academia and industry

Doody's Reviews

Score: 78/100
3/5 Stars
Read Review
Go to Doody's Review page

Quotes, Reviews or Testimonials

"This book details information on viral pathways in the cell and the mechanism of antiviral action and would be very useful to scientists working on antiviral agents. "

-- Rebecca Horvat, PhD, D(ABMM) (University of Kansas Medical Center) Doody's Review


This will appeal to scientists working on new compounds that act to interrupt the viral pathogenesis pathways. It also might be of interest to those involved in the study of cell processes.

Table of Contents

Similar Resources